{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} An Introduction to Gender-Affirming Hormone Therapy for Transgender and Gender-Nonbinary Patients
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Learning Objectives
After completing this continuing education activity you will be able to:
- Explain gender incongruence and cultural competence.
- Describe the informed consent model (ICM) of care.
Disclosures
The authors, faculty, and staff have no financial relationships with any ineligible organizations regarding this educational activity.
Price:
$12.95
Credits:
- NBCC 1.0 CH
Wolters Kluwer Health, Inc./Lippincott Continuing Professional Development has been approved by
NBCC as an Approved Continuing Education Provider, ACEP No. 6855. Programs that do not qualify
for NBCC credit are clearly identified. Wolters Kluwer Health, Inc./Lippincott Continuing
Professional Development is solely responsible for all aspects of the programs.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Mental Health Counselor
Test Code: NP0322A-MHC
Published: Mar 2022
Expires: 10/31/2024
Sources:
Allied Health Collection
Required Passing Score: 8/10 (80%)